menu
    • menu
    [{"orgOrder":0,"company":"Unity Health Toronto","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"CANADA","productType":"Controlled Substance","year":"2018","type":"Inapplicable","leadProduct":"Cannabinol","moa":"cannabinol derivatives","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase II\/ Phase III","graph3":"Unity Health Toronto","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Unity Health Toronto \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"Unity Health Toronto \/ Undisclosed"},{"orgOrder":0,"company":"Robert Wood Johnson Barnabas Health","sponsor":"Brielle Orthopedics | University Orthopedics Associates","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Methylprednisolone","moa":"Glucocorticoid receptor","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase II\/ Phase III","graph3":"Robert Wood Johnson Barnabas Health","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Robert Wood Johnson Barnabas Health \/ Brielle Orthopedics | University Orthopedics Associates","highestDevelopmentStatusID":"9","companyTruncated":"Robert Wood Johnson Barnabas Health \/ Brielle Orthopedics | University Orthopedics Associates"},{"orgOrder":0,"company":"University of South Florida","sponsor":"Pacira BioSciences","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Bupivacaine","moa":"Sodium channel protein type IV alpha subunit","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase II\/ Phase III","graph3":"University of South Florida","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of South Florida \/ Pacira BioSciences","highestDevelopmentStatusID":"9","companyTruncated":"University of South Florida \/ Pacira BioSciences"}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Robert Wood Johnson Barnabas Health

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Robert Wood Johnson Barnabas Health

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Methylprednisolone

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Study Phase : Phase II/ Phase III

                            Sponsor : Brielle Orthopedics | University Orthopedics Associates

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand

                            Details : Methylprednisolone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hand Injuries.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 12, 2021

                            Lead Product(s) : Methylprednisolone

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Brielle Orthopedics | University Orthopedics Associates

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            University of South Florida

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University of South Florida

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bupivacaine

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Study Phase : Phase II/ Phase III

                            Sponsor : Pacira BioSciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Exparel for Total Shoulder Pain

                            Details : Exparel (Bupivacaine Liposome) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Shoulder Pain.

                            Product Name : Exparel

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            November 13, 2018

                            Lead Product(s) : Bupivacaine

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Pacira BioSciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Unity Health Toronto

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Unity Health Toronto

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cannabinol

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Study Phase : Phase II/ Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement

                            Details : Cannabinol is a Controlled Substance drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Arthroplasty, Replacement, Knee.

                            Product Name : Undisclosed

                            Product Type : Controlled Substance

                            Upfront Cash : Inapplicable

                            September 18, 2018

                            Lead Product(s) : Cannabinol

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth